Is it time to shift to better characterization of patients in trials assessing novel antidepressants? An example of two relapse prevention studies with agomelatine

Míreanna comhchosúla

• Is it time to shift to better characterization of patients in trials assessing novel antidepressants? An example of two relapse prevention studies with agomelatine.
  de réir: Goodwin, G, et al.
  Foilsithe / Cruthaithe: (2013)
• Long-term efficacy of agomelatine, a novel antidepressant, in the prevention of relapse in out-patients with major depressive disorder
  de réir: Goodwin, G, et al.
  Foilsithe / Cruthaithe: (2007)
• Antidepressant effect in older depressed patients: the lessons of two agomelatine trials
  de réir: Goodwin, G, et al.
  Foilsithe / Cruthaithe: (2017)
• Long-term treatment with agomelatine: prevention of relapse in patients with Major Depressive Disorder over 10 months
  de réir: Goodwin, G, et al.
  Foilsithe / Cruthaithe: (2008)
• Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial.
  de réir: Goodwin, G, et al.
  Foilsithe / Cruthaithe: (2009)